key: cord-0703482-wx1skp5e
authors: Orso, Francesco; Migliorini, Marta; Herbst, Andrea; Ghiara, Camilla; Virciglio, Simona; Camartini, Viola; Tognelli, Silvia; Lucarelli, Giulia; Fortini, Giacomo; Pratesi, Alessandra; Mossello, Enrico; Bari, Mauro Di; Marchionni, Niccolò; Ungar, Andrea; Baldasseroni, Samuele; Fattirolli, Francesco
title: Protocol for Telehealth Evaluation and Follow-up of Patients with Chronic Heart Failure during the COVID-19 Pandemic
date: 2020-10-16
journal: J Am Med Dir Assoc
DOI: 10.1016/j.jamda.2020.10.017
sha: 4a999b7a8c7660c9bb24d1f4398a733d3b3b5bc0
doc_id: 703482
cord_uid: wx1skp5e

Because of Coronavirus Disease 2019 (COVID-19) pandemic, we were forced to cancel scheduled visits for nearly 150 patients followed in our heart failure (HF) outpatient clinic. Therefore, we structured a telephone follow-up, developing a standardized 23 item questionnaire from whom we obtained the Covid-19-HFscore. The questionnaire, was built to reproduce our usual clinical evaluation investigating patient’s social and functional condition, mood, adherence to pharmacological and non-pharmacological recommendations, clinical and hemodynamic status, pharmacological treatment and need to contact emergency services. The score was used as a clinical tool to define patients’ clinical stability and timing of the following telephone contact on the basis of the assignment to progressively increasing risk score groups: green (0-3), yellow (4-8) and red (≥9). Here we present our experience applying the score in the first thirty patients who completed the four weeks follow-up, describing baseline clinical characteristics and events that occurred in the period of observation.

Because of Coronavirus Disease 2019 (COVID-19) pandemic, we were forced to cancel scheduled 3 visits for nearly 150 patients followed in our heart failure (HF) outpatient clinic. Therefore, we 4 structured a telephone follow-up, developing a standardized 23 item questionnaire from whom we 5 obtained the Covid-19-HFscore. The questionnaire, was built to reproduce our usual clinical 6 evaluation investigating patient's social and functional condition, mood, adherence to 7 pharmacological and non-pharmacological recommendations, clinical and hemodynamic status, 8 pharmacological treatment and need to contact emergency services. The score was used as a clinical 9 tool to define patients' clinical stability and timing of the following telephone contact on the basis 10 of the assignment to progressively increasing risk score groups: green (0-3), yellow (4-8) and red 11 (≥9). 12

Here we present our experience applying the score in the first thirty patients who completed the 13 four weeks follow-up, describing baseline clinical characteristics and events that occurred in the 14 period of observation .  15   16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  INTRODUCTION  34  35 By the end of 2019, SARS-CoV-2 produced a rapidly expanding epidemic in Wuhan, China 1 

World Health Organization (WHO) termed this illness Coronavirus Disease 2019 . 37

Because of the numerous cases that occurred in Italy, on March 9, 2020 the Italian government 38 imposed a total lockdown and social isolation. After this decision, physicians were forced to review 39 their outpatient activity, limiting ambulatory visits to exceptional cases, trying to reduce the risk 40 derived from interpersonal contact, especially in elderly and frail patients. Telehealth has therefore 41 gained greater prominence in the management of chronic conditions, with the purpose to delivery 42 care remotely. Randomized clinical trials on tele-health interventions for chronic heart failure (HF) 43

suggested that either tele-monitoring 2-4 , or telephone support by structured questionnaires 5-9 did not 44 reduce hospital readmissions or mortality. More recently, however, a pilot study addressing the 45 potential of audio/video interaction (known as Virtual Visits, VVs) compared to in-person visits in 46 post-discharge care of HF showed promising results, and other studies reported improved symptom 47 control and quality of life with tele-monitoring of HF patients 10-12 . Due to overall weak evidence, 48

the European Society of Cardiology guidelines do not recommend any specific tele-health 49 instrument in the management of HF 13 . Nevertheless, as the exceptional COVID-19 pandemic 50 briskly led to reduced clinical control, we developed a standardized questionnaire suitable for 51 telephone administration to older HF patients and/or caregivers. 52

Transition from a HF outpatient clinic to a structured telephone follow-up 54

Since 2017, we have structured a multidisciplinary HF clinic as a hospital-based outpatient unit in a 55 tertiary level academic hospital, managed by a team of cardiologists, geriatricians and HF-trained 56 nurses. The main mission of this unit is to assist patients within 2 weeks of hospital discharge after 57 acute HF failure, through follow-up programs tailored individually to severity of disease and 58 clinical stability. 59

Due to the emergent COVID-19 pandemic several "non-urgent" outpatient services like ours 60 were suddenly closed. We were taking care of almost 150 patients with follow-up visits already 61 scheduled over the following weeks. 62

Here we present the development and implementation of a standardized questionnaire, 63 currently administered to our HF patients and/or caregivers during scheduled telephone contacts to 64 evaluate clinical stability and to remotely assist patients. An English version of the questionnaire is 65 shown in Figure 1 . In accordance with current Italian privacy laws, the questionnaire was 66 anonymised, and patients were identified by a numeric code, date of birth and gender. The 23 item 67 questionnaire was designed for rapid administration during telephone interview, with a median call duration of 6 minutes. It was designed to investigate seven domains: 1) social and functional 69 condition; 2) mood; 3) adherence to pharmacological and non-pharmacological recommendations 70 (blood pressure, heart rate, weight monitoring and fluid intake control); 4) clinical and 71 hemodynamic status; 5) recording of laboratory tests; 6) current pharmacological treatment; 7) 72 recent evaluation by family physician or need to contact emergency services followed or not by 73 hospitalisation, and reasons for these medical contacts. General and pharmacological 74 recommendations as well as the following telephone contact were finally recorded. 75

We decided to evaluate mood using a numerical scale. This approach was chosen instead of 76 applying more complex and validated questionnaires 14,15 to spare overall time of interview. 77

Similarly, we limited functional status assessment to two questions regarding the need of assistance 78 to purchase food and medicines and needed help with therapy, which are fundamental aspects of 79 basic care. Adherence to pharmacotherapy was evaluated by using one single question instead of 80 more complex and time consuming validated tools 16 . Current pharmacotherapy (GDMTs and the 81 need of high-dose loop diuretics, such as furosemide ≥ 250 mg daily, alone or in combination with 82 metolazone), as well as the need of incremental dose since previous contact were also recorded. 83

Then, we investigated the adherence to prior patient education of self-monitored parameters and 84 non-pharmacological recommendations on which all of our patients have been trained. We further 85 In order to determine the timing of the next telephonic evaluation, we decided to weight 93 questions regarding clinical and hemodynamic status, adherence to pharmacological and non-94 pharmacological recommendations, therapeutic changes and need for hospitalisation by scoring the 95 answers (from 1 to 3) to build a score. This was done upon clinical judgment and review of current 96 HF literature, after collegial discussion and final agreement of all authors. The sum of individual 97 scores represented the novel TeleHFCovid19-score, ranging from 0 to 29. Based on such score, 98 three groups of patients were identified by arbitrary cut-off levels ( Figure 1 ): the green (score <4), 99 the yellow (score 4-8) and the red (score ≥9) group, for which next telephonic evaluation was 100 planned respectively after four, two and one week respectively. Alternatively, the red group could 101 receive recommendation for urgent hospital evaluation.

Here we report our experience with the first thirty patients who completed the four weeks follow-105 up. Baseline epidemiological and clinical characteristics of these patients divided according to the 106 score assigned during the first call in the three colour groups are shown in Table 1 . Sixty percent of 107 patients were assigned to the hypothetically low-risk green group, seventeen percent to the high risk 108 red group and the remaining to the intermediate risk yellow group. Mean age of our study 109 population was 84.4 years and slightly higher, although non significantly, in the red group. Nearly 110 half of this sample of patients presented heart failure with reduced ejection fraction (HFrEF) and 111 just above half had an ischemic aetiology. Patients in the yellow and red groups were more 112 frequently treated with high dose loop diuretics. Figure 2a shows scores variation and change of 113 group as well as events occurring during the first month for each patient. We observed two deaths 114 (6.7%), one in the red group and one in the green group and five hospital admissions (16.7%), of 115 which, three in the yellow group and one in the green and red group respectively. Causes of 116 hospitalization are reported in Table 1 . Figure 2b shows colour groups variation at the end of the 117 observation period: at four weeks three patients had died, one patient was still hospitalized, the 118 percentage of "green patients" remained stable (60%), while"red patients" decreased from from 17 119 to 3% andthe percentage of "yellow patients" raised from 23 to 27%. 120

Because of the rapid lockdown of many outpatient services and of the simultaneous need of 122 re-allocating many health care professionals for the management of severe COVID-19 cases 123 requiring hospitalization, a rapid reorganization of our outpatient clinical activity was necessary, to 124 continue providing specialized medical assistance to older, comorbid HF patients. John F. Kennedy 125 said once that "When written in Chinese, the word "crisis" is composed of two characters-one 126 represents danger, the other represents opportunity". The impossibility to perform a physical and 127 instrumental examination in a complex clinical syndrome such as HF represents a major challenge. 128

In this regard, the Heart Failure Society of America recently suggested to cope with this emergency 129 by using visual visits, implementing audio contact with a physical video-evaluation 17 . Nevertheless, 130

considering the advanced average age of our patients, we argued that not all users could carry out a 131 video-call or feel comfortable with this technology. For these reasons, we opted for a telephone-132 visit, being aware of its limits. 133

From this preliminary experience we may report several positive points. Patients have 134

favourably accepted this telephone follow-up in a difficult moment in which they felt isolated and 135 particularly vulnerable. Furthermore, by optimization of GDMTs and especially by adjusting 136 diuretic dose we managed to improve symptoms in several patients obtaining a score reduction (and 137 change of colour group allocation). Moreover, we were able to identify patients poorly adherent to 138 non-pharmacological recommendations and reinforce the importance of following them. We also 139 managed to correctly select the timing of hospital admission for elective/urgent procedures (eg. were investigated, the Covid-19-HF score is focused on HF management and does not take in 147 account frailty-related risks and the burden of non-cardiovascular comorbidities. Consequently, in 148 this first sample of patients the score has not been able to identify and prevent non-HF related 149 complications (eg. cerebrovascular events, sepsis, Covid-19 pneumonia). Secondly, by using only a 150 telephone interview we might overestimate or in other cases underestimate the patient's real clinical 151 condition and in selected patients the use of tele-visits could be useful. Furthermore, in some cases 152 evaluations might have been non-objective but the result of caregivers perception and interpretation. 153

The COVID-19-HF score, should not be considered a prognostic score at present, because 156 its prognostic power needs to be validated in a longitudinal follow-up, currently ongoing. Until 157 then, it should be considered a potentially useful clinical tool to be used in this emergency situation 158 which, through a standardized approach, could help physicians maintaining the follow-up of their 159 patients and appropriately scheduling re-evaluation though next telephonic contact and identifying 160 patients at greatest risk of imminent instability, who may need urgent hospital evaluation. 161

Furthermore, at the end of the pandemic, this instrument could also represent a useful resource in 162 the management of low-risk HF patients, allowing clinicians to appropriately schedule clinical re-163 evaluation in a moment when, with the re-opening of outpatient services, the demand will be very 164 high. Moreover, this type of approach could also be transferred to other chronic conditions whose 165 

J o u r n a l P r e -p r o o f 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet

Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)

Telemonitoring in patients with heart failure

Impact of remote telemedical management on mortality and hospitalizations 205 in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart 206 failure study

Comparative effectiveness of transitional care services in patients 209 discharged from the hospital with heart failure: a systematic review and network meta-analysis. Eur 210 J Heart Fail

A randomized trial of telenursing to reduce 212 hospitalization for heart failure: patient-centered outcomes and nursing indicators

Evaluation of home telehealth following hospitalization for heart failure: a randomized trial

Noninvasive home 218 telemonitoring for patients with heart failure at high risk of recurrent admission and death: the 219

Network-Home-Care Management System (TEN-HMS) study

A 222 randomized trial of home telemonitoring in a typical elderly heart failure population in North West 223

London: results of the Home-HF study

Starling 225 RC. Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement 226 from the Heart Failure Society of America

Quality of life in patients with advanced 228 heart failure

Impact of 230 telemonitoring on health status

ESC 234 guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the 235 diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology 236 (ESC)

Screening tests for geriatric depression

Screening for major depression disorders in medical 240 inpatients with the Beck Depression Inventory for Primary Care

Predictive validity of a medication adherence 242 measure in an outpatient setting

Virtual Visits for Care of Patients with Heart Failure in 244

We would like to acknowledge Mrs Marzia Conforti, Mrs Katia Zini, Mrs Adriana Bambi, Mrs Maddalena Ciompi, Mrs Silvia Burchi, Mrs. Francesca Valeri, Mrs. Francesca Nesti, Mrs Rita Peruzzi and Mr Damasco Donati for their precious and irreplaceable clinical work in our HF outpatient clinic and for the support in managing the telephone follow-up.